Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Michael Raya Insider Profile
4 Followers
Michael Raya, Country Chief Executive at Hikma Pharmaceuticals, holds 192.39K shares in Hikma Pharmaceuticals (Ticker: GB:HIK).
Michael Raya Hikma Pharmaceuticals (HIK)Country Chief Executive
Hikma Pharmaceuticals (HIK)
Country Chief Executive
Ranked #56,639 out of 97,944 Corporate Insiders
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
-4.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
Country Chief Executive
Roles that Michael Raya holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:May 19, 2016 - May 19, 2017
Return:+12.30%
The most profitable trade made by Michael Raya
Michael Raya's Trading History
List of latest transactions for each holding click on a transaction to see Michael Raya's performance on stock
You May Also Like
Michael Raya insider profile FAQ
What is the percentage of profitable transactions made by Michael Raya?
The percentage of profitable transactions made by Michael Raya is 25%.
What is the average return per transaction made by Michael Raya?
The average return per transaction made by Michael Raya is -4.90%.
What stocks does Michael Raya hold?
Michael Raya holds: GB:HIK stocks.
What was Michael Raya’s latest transaction?
Michael Raya latest transaction was an Uninformative Buy of ―.
What was Michael Raya's most profitable transaction?
Michael Raya’s most profitable transaction was an Informative Sell of GB:HIK stock on May 19, 2016. The return on the trade was 12.30%.
What is Michael Raya's role in Hikma Pharmaceuticals?
Michael Raya's role in Hikma Pharmaceuticals is Country Chief Executive.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.